None listed
Conditions
Interventions
Intervention 1: Intervention Group: Patients in the intervention group will first complete the dental anxiety questionnaire to assess baseline anxiety levels. Following this, their heart rate, blood p
however, a nasal cannula will be placed without oxygen flow to maintain procedural consistency. The patients will breathe normally for 3 minutes prior to the administration of local anesthesia. Anxiet
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: The person is systemically free of any symptoms (absence of any heart, lung, nervous or mental disease) The person is of legal age over 17 years and under 35 years The person needs wisdom tooth surgery
Exclusion criteria
Exclusion criteria: Patient’s withdrawal of consent at any stage of the study. Surgical procedure duration exceeding 60 minutes. Occurrence of severe and unpredictable complications during treatment, such as excessive bleeding, lithotripsy, etc. Use of analgesics or anxiolytic medications within three days prior to the procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The participants' level of dental anxiety. Timepoint: Before and after the intervention. Method of measurement: Participants’ dental anxiety will be assessed using the Dental Anxiety Inventory (DAI), a validated and reliable questionnaire. The DAI consists of 36 items that have been translated into Persian. Each item is rated on a 5-point Likert scale ranging from 1 (strongly disagree), 2 (disagree), 3 (neutral), 4 (agree), to 5 (strongly agree). The total score is calculated by summing the responses, and the level of dental anxiety is determined according to the scoring criteria defined by the questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before, during, and after the intervention. Method of measurement: Systolic and diastolic blood pressure will be continuously monitored using an Omron M3 sphygmomanometer on the patient’s left arm. Measurements will be taken from 5 minutes before the procedure, throughout the intervention, and up to 5 minutes after the procedure.;Heart rate. Timepoint: Before, during, and after the intervention. Method of measurement: The patient’s heart rate will be continuously monitored using an Omron M3 sphygmomanometer on the left arm, starting 5 minutes before the procedure and continuing until 5 minutes after the procedure.;Peripheral oxygen saturation. Timepoint: Before, during, and after the intervention. Method of measurement: The patient’s peripheral oxygen saturation (SpO2) will be continuously monitored using a Masimo Radical-7 pulse oximeter, attached to the patient’s finger, from 5 minutes before the procedure until 5 minutes after the procedure. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Mahvidi
Birjand University of Medical Sciences
Outcome results
None listed